- Find
- Manage
- Resources
Is Simvastatin Generic For Lipitor?
As the generic formula of Zocor (simvastatin) became the third generic statin on the market in June, many patients taking Lipitor are finding the drug harder and more expensive to get. In an effort to cut costs, many insurance companies are requiring patients to switch from Lipitor to a generic statin, or the companies are raising co-pays on Lipitor to encourage patients to make the change themselves.
Read moreMore information on "Is Simvastatin Generic For Lipitor?"
From Our Sources
Judge rules in favor of generic Lipitor
A Norwegian court has ruled that a generic formula of Lipitor made by drugmaker Ranbaxy does not infringe on Pfizer's patents on... Read more »
Generic Lipitor blocked again
Drugmaker Pfizer has once again stopped a generic form of Lipitor from hitting the market. A Danish court has issued an injunction to stop Ranbaxy... Read more »
Lipitor more effective than generic Zocor, study finds
Drugmaker Pfizer says that a recent analysis of insurance data found that patients who took Lipitor had a 14-percent reduction in the risk of... Read more »
Study: Lipitor beats generic Zocor for lowering hospital costs...
Lipitor lowers hospitalization costs for patients with heart disease more than generic Zocor, a new study suggests. Researchers found that study... Read more »
Court ruling may speed availability of generic Lipitor
An ongoing legal battle between Lipitor maker Pfizer and generic drugmaker Ranbaxy may have reached a turning point. A U.S. court has ruled that one... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
